We are live on
!
Find out more
NanoViricides
NNVC
NNVC
40 hedge funds and large institutions have $630K invested in NanoViricides in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
0.05% less ownership
Funds ownership: 0.3% → 0.25% (-0.05%)
7% less funds holding
Funds holding: 43 → 40 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
54% less capital invested
Capital invested by funds: $1.36M → $630K (-$727K)
Holders
40
Holders Change
-3
Holders Change %
-6.98%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
5
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$13.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9.09K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$7.78K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$4.67K |
| 5 |
Millennium Management
New York
|
+$4.27K |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$160K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$42.4K |
| 3 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
-$18K |
| 4 |
Renaissance Technologies
New York
|
-$10.5K |
| 5 |
Goldman Sachs
New York
|
-$5K |
